Oxygenta Pharmaceutical reports standalone net loss of Rs 4.93 crore in the September 2025 quarter
Sales rise 2.07% to Rs 14.30 crore
Net Loss of Oxygenta Pharmaceutical reported to Rs 4.93 crore in the quarter ended September 2025 as against net loss of Rs 2.85 crore during the previous quarter ended September 2024. Sales rose 2.07% to Rs 14.30 crore in the quarter ended September 2025 as against Rs 14.01 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales14.3014.01 2 OPM %-31.96-15.49 -PBDT-5.58-2.11 -164 PBT-6.44-2.77 -132 NP-4.93-2.85 -73Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content